Evolution Advisers’s HCA Healthcare HCA Stock Holding History

Evolution Advisers’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4K	Buy	12 +1	+9%	+$423	﹤0.01%	158
2026 Q1	$5K	Hold	11	–	–	﹤0.01%	142
2025 Q4	$5K	Sell	11 -344	-97%	-$160K	﹤0.01%	150
2025 Q3	$151K	Hold	355	–	–	0.07%	49
2025 Q2	$136K	Sell	355 -35	-9%	-$12.6K	0.07%	50
2025 Q1	$134K	Hold	390	–	–	0.07%	51
2024 Q4	$117K	Sell	390 -77	-16%	-$26.9K	0.06%	52
2024 Q3	$189K	Buy	467 +379	+431%	+$139K	0.1%	40
2024 Q2	$28K	Hold	88	–	–	0.02%	106
2024 Q1	$30K	Hold	88	–	–	0.02%	110
2023 Q4	$24K	Sell	88 -77	-47%	-$19K	0.02%	119
2023 Q3	$40K	Hold	165	–	–	0.03%	70
2023 Q2	$50K	Hold	165	–	–	0.04%	65
2023 Q1	$43K	Hold	165	–	–	0.03%	64
2022 Q4	$39K	Sell	165 -150	-48%	-$33.6K	0.03%	72
2022 Q3	$57K	Hold	315	–	–	0.05%	55
2022 Q2	$55K	Hold	315	–	–	0.04%	57
2022 Q1	$78K	Hold	315	–	–	0.06%	52
2021 Q4	$80K	Buy	+315	New	+$77.1K	0.06%	44

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Evolution Advisers's HCA Position: Q2 2026 in Review

Evolution Advisers increased its HCA Healthcare (HCA) stake by 9.1% in Q2 2026, buying an estimated $423 and bringing the position to 12 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #158.

Evolution Advisers first reported a position in HCA in Q4 2021 and has held it in 19 quarters since. The position peaked at $189K in Q3 2024. 1,340 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Evolution Advisers held 12 shares of HCA Healthcare worth $4K as of Q2 2026.
Evolution Advisers bought 1 HCA Healthcare share in Q2 2026, an estimated $423.
HCA Healthcare made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #158 holding.
Evolution Advisers first reported a position in HCA Healthcare in Q4 2021 and has held it in 19 quarters since.
Evolution Advisers's HCA Healthcare position peaked at $189K in Q3 2024.
1,340 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.